Earllondra Brooks is a Philadelphia, Pennsylvania based neurologist who is specialized in Neurology. Active license number of Earllondra Brooks is MD485456 for Neurocritical Care in Pennsylvania. Her current practice location is 3400 Spruce Street, 2 Ravdin, Philadelphia. Patients can reach her at 954-461-3595. Earllondra Brooks is MD in Neurology and her NPI number (Unique professional ID assigned by NPPES) is 1255828018. Earllondra Brooks specializes in the diagnosis and treatment of diseases or impaired function of the brain, spinal cord, peripheral nerves, muscles, autonomic nervous system, and blood vessels that relate to these structures.
Complete Profile:
Earllondra Brooks speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1255828018
NPI Enumeration Date:
17 Apr, 2018
NPI Last Update On:
28 Aug, 2024
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Earllondra Brooks are as mentioned below.
License Number
Specialization
State
Status
MD485456
Neurocritical Care
Pennsylvania
Primary
91806
Neurology
Georgia
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Earllondra Brooks 3400 Spruce St, 3 W Gates Philadelphia, Pennsylvania
Zip:
19104
Phone Number:
954-461-3595
Patients can reach Earllondra Brooks at 3400 Spruce Street, 2 Ravdin, Philadelphia, Pennsylvania or can call to book an appointment on 954-461-3595.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.